Taking place one year on from the publication of the Independent Cancer Taskforce’s five year plan, delegates will consider progress and next steps for implementing recommendations from the report.

Sessions will focus on priorities for meeting four-week diagnosis targets, the role of newly formed Cancer Alliances, and the impact of cancer vanguard sites on the commissioning and provision of services.

The conference will also be an opportunity to discuss the future for accessing new treatments, with the Cancer Drugs Fund to be reformed from July 2016.